Predictive Oncology Inc (NASDAQ:POAI) currently has a daily average trading volume of 1.18M but it saw 48285431 shares traded in last market. With a market cap of 9.87M USD, the company’s current market price of $1.48 came rising about 16.54 while comparing to the previous closing price of $1.27. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.76 and as low as $0.55. In the recent trading on the day, stock has struck highest price mark of $1.3146 while lowest mark touched by it was $2.3699.
Taking a look at 20-day trading activity of Predictive Oncology Inc (POAI) gives us an average price of $1.1530, while its current price level is -60.64% below from 52-week high level whereas it is 169.09% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.9166 while that of 200 days or SMA-200 reads an average of $1.0761. A closer look into the stock’s movement over the week reveals that its volatility is standing at 27.05% during that period while stretching the period over a month that increases to 27.46%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 61.56 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which initiated the stock as “Buy” in its note to investors issued on August 19, 2024, recommending a price target of $3 for it.
Over the week, POAI’s stock price is moving 23.33% up while it is 102.74% when we observe its performance for the past one month. Year-to-date it is 80.49% up and over the past year, the stock is showing a downside performance of -49.83%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0. In next quarter, company is expected to be making quarterly sales of $1.5M as analysts are expecting the sales for current fiscal year at $1.39M and seeing the company making $9.33M in sales next year. Moreover, analysts are in estimates of $350k for current-quarter revenue.
Currently, Predictive Oncology Inc’s total number of outstanding shares is 6.67M with 2.16% of that held by the insiders while 4.01% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -380.51% and return on equity (ROE) at -193.25%. Stock’s beta reads 1.24. Stock has a price to book (P/B) ratio of 5.02 while price to sale or P/S ratio amounts to 7.15. Its return on asset (ROA) is -102.54% on average.
